Seth Ettenberg, PhD
Chief Scientific Officer
As a founding member of the Unum team, Seth is a cancer biologist and drug development scientist with experience leading teams in biotechnology and large pharmaceutical drug discovery settings. He brings a strong track record of immuno-oncology experience to Unum, having lead multiple biologics programs from invention through clinical development during his career. Prior to Unum, Seth most recently served as Head of Novartis Oncology Biotherapeutics, Cambridge Site. Seth received his PhD from the Uniform Services University of the Health Sciences and completed his post-doctoral training at the National Cancer Institute.